In vivo identification of novel STAT5 target genes

STAT5A and STAT5B proteins belong to the family of signal transducers and activators of transcription. They are encoded by two separate genes with 91% identity in their amino acid sequences. Despite their high degree of conservation, STAT5A and STAT5B exert non-redundant functions, resulting at least in part from differences in target gene activation. To better characterize the differential contribution of STAT5A and STAT5B in gene regulation, we performed single or double knockdown of STAT5A and STAT5B using small interfering RNA. Subsequent gene expression profiling and RT-qPCR analyses of IL-3-stimulated Ba/F3-β cells led to the identification of putative novel STAT5 target genes. Chromatin immunoprecipitation assays analyzing the corresponding gene loci identified unusual STAT5 binding sites compared to conventional STAT5 responsive elements. Some of the STAT5 targets identified are upregulated in several human cancers, suggesting that they might represent potential oncogenes in STAT5-associated malignancies.

[1]  W. Leonard,et al.  The role of Stat5a and Stat5b in signaling by IL-2 family cytokines , 2000, Oncogene.

[2]  M. Bourguet-Kondracki,et al.  STAT5B-mediated Growth Hormone Signaling Is Organized by Highly Dynamic Microtubules in Hepatic Cells* , 2005, Journal of Biological Chemistry.

[3]  B. Groner,et al.  Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. , 1994, The EMBO journal.

[4]  Shizuo Akira,et al.  Functional Roles of STAT Family Proteins: Lessons from Knockout Mice , 1999, Stem cells.

[5]  V. Dixit,et al.  Activation and accumulation of B cells in TACI-deficient mice , 2001, Nature Immunology.

[6]  X. Liu,et al.  Identification of Human STAT5-dependent Gene Regulatory Elements Based on Interspecies Homology* , 2006, Journal of Biological Chemistry.

[7]  J. Johnston,et al.  Deacetylase Activity Is Required for Recruitment of the Basal Transcription Machinery and Transactivation by STAT5 , 2003, Molecular and Cellular Biology.

[8]  L. Hennighausen,et al.  Distinctive Roles of STAT5a and STAT5b in Sexual Dimorphism of Hepatic P450 Gene Expression , 1999, The Journal of Biological Chemistry.

[9]  A. Schäffer,et al.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans , 2005, Nature Genetics.

[10]  W. Leonard,et al.  An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. , 1997, Immunity.

[11]  R. Berger,et al.  Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells. , 2000, Blood.

[12]  V. Dixit,et al.  TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice , 2001, Nature Immunology.

[13]  T. Hoey,et al.  Cooperative DNA Binding and Sequence-Selective Recognition Conferred by the STAT Amino-Terminal Domain , 1996, Science.

[14]  U. Schindler,et al.  Interaction of STAT5 Dimers on Two Low Affinity Binding Sites Mediates Interleukin 2 (IL-2) Stimulation of IL-2 Receptor α Gene Transcription* , 1997, The Journal of Biological Chemistry.

[15]  Nicola Gebbia,et al.  STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.

[16]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[17]  B. Grimbacher,et al.  To switch or not to switch – the opposing roles of TACI in terminal B cell differentiation , 2007, European journal of immunology.

[18]  J. Grandis,et al.  Differential function of STAT5 isoforms in head and neck cancer growth control , 2002, Oncogene.

[19]  R. Panettieri,et al.  Anaphylatoxin C3a receptors in asthma , 2005, Respiratory research.

[20]  H. Rui,et al.  Differential Control of the Phosphorylation State of Proline-juxtaposed Serine Residues Ser725 of Stat5a and Ser730 of Stat5b in Prolactin-sensitive Cells* , 1998, The Journal of Biological Chemistry.

[21]  T. Decker,et al.  Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons , 1996, Molecular and cellular biology.

[22]  U. Vinkemeier,et al.  Nucleocytoplasmic shuttling of STAT transcription factors. , 2004, European journal of biochemistry.

[23]  R. Geha,et al.  TACI is mutant in common variable immunodeficiency and IgA deficiency , 2005, Nature Genetics.

[24]  J. Becker,et al.  STAT5 Contributes to Interferon Resistance of Melanoma Cells , 2005, Current Biology.

[25]  K. Arai,et al.  Stat5B Shuttles Between Cytoplasm and Nucleus in a Cytokine-Dependent and -Independent Manner1 , 2002, The Journal of Immunology.

[26]  W. Berdel,et al.  Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways. , 2000, Blood.

[27]  Jos Jonkers,et al.  Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.

[28]  Hsien-yu Wang,et al.  Overexpression of mitogen-activated protein kinase phosphatases MKP1, MKP2 in human breast cancer. , 2003, Cancer letters.

[29]  U. Vinkemeier,et al.  A Single Residue Modulates Tyrosine Dephosphorylation, Oligomerization, and Nuclear Accumulation of Stat Transcription Factors* , 2004, Journal of Biological Chemistry.

[30]  R. Perona,et al.  MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer , 2006, Oncogene.

[31]  L. Ivashkiv,et al.  Signaling by STATs , 2004, Arthritis research & therapy.

[32]  L. Hennighausen,et al.  A Single Amino Acid in the DNA Binding Regions of STAT5A and STAT5B Confers Distinct DNA Binding Specificities* , 1998, The Journal of Biological Chemistry.

[33]  M. Martinez-Moczygemba,et al.  Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. , 2003, The Journal of allergy and clinical immunology.

[34]  D. Corry,et al.  Absence of the Complement Anaphylatoxin C3a Receptor Suppresses Th2 Effector Functions in a Murine Model of Pulmonary Allergy1 , 2002, The Journal of Immunology.

[35]  H. Ahn,et al.  Transforming growth factor-β downregulates interleukin-2-induced phosphorylation of signal transducer and activator of transcription 5 in human renal cell carcinoma , 2007, Journal of Cancer Research and Clinical Oncology.

[36]  David M. Livingston,et al.  E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1 , 2004, Molecular and Cellular Biology.

[37]  J. Griffin,et al.  Role of FLT3 in leukemia. , 2002, Current opinion in hematology.

[38]  R. Bram,et al.  NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. , 1997, Science.

[39]  K. Shuai,et al.  Modulation of STAT signaling by STAT-interacting proteins , 2000, Oncogene.

[40]  Roy Garcia,et al.  STATs in oncogenesis , 2000, Oncogene.

[41]  Corinne M. Silva.  Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis , 2004, Oncogene.

[42]  J. Rosen,et al.  Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[43]  E. White.  The pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines. , 2003, Genes & development.

[44]  B. Groner,et al.  Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[45]  L. Nie,et al.  STAT5‐induced Id‐1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPβ , 2003, The EMBO journal.

[46]  R. Snell,et al.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Berger,et al.  The TEL-Jak2 oncoprotein induces Socs1 expression and altered cytokine response in Ba/F3 cells , 2001, Oncogene.

[48]  B. Groner,et al.  p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response. , 1998, Molecular endocrinology.

[49]  H. Bojar,et al.  STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases. , 2006, The Journal of investigative dermatology.

[50]  M. Schartl,et al.  Activation of STAT5 triggers proliferation and contributes to anti-apoptotic signalling mediated by the oncogenic Xmrk kinase , 2002, Oncogene.

[51]  A. Mui,et al.  STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells , 1999, The EMBO journal.

[52]  G. Müller,et al.  Insulin selectively activates STAT5b, but not STAT5a, via a JAK2‐independent signalling pathway in Kym‐1 rhabdomyosarcoma cells , 1999, FEBS letters.

[53]  D. Frank,et al.  Isolation of Unique STAT5 Targets by Chromatin Immunoprecipitation-based Gene Identification* , 2004, Journal of Biological Chemistry.

[54]  Kenji Nakanishi,et al.  SOCS-1 participates in negative regulation of LPS responses. , 2002, Immunity.

[55]  J. Ihle,et al.  Naturally occurring dominant negative variants of Stat5 , 1996, Molecular and cellular biology.

[56]  E. Fish,et al.  Stats: multifaceted regulators of transcription. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[57]  H. Friess,et al.  Down-regulation of the dual-specificity phosphatase MKP-1 suppresses tumorigenicity of pancreatic cancer cells. , 2003, Gastroenterology.

[58]  C. Litterst,et al.  NCoA-1/SRC-1 Is an Essential Coactivator of STAT5 That Binds to the FDL Motif in the α-Helical Region of the STAT5 Transactivation Domain* , 2003, Journal of Biological Chemistry.

[59]  J. Turkson,et al.  STAT proteins: novel molecular targets for cancer drug discovery , 2000, Oncogene.

[60]  P. Valdez,et al.  Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. , 2003, Immunity.

[61]  W. Hiddemann,et al.  Overexpression and constitutive activation of FLT3 induces STAT5 activation in primary acute myeloid leukemia blast cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[62]  K. Todokoro,et al.  Interleukin 3 activates not only JAK2 and STAT5, but also Tyk2, STAT1, and STAT3. , 1996, Biochemical and biophysical research communications.

[63]  I. Barash.  Stat5 in the mammary gland: Controlling normal development and cancer , 2006, Journal of cellular physiology.

[64]  F. Prósper,et al.  Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.

[65]  H. Rui,et al.  Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. , 1999, Cytokine & growth factor reviews.

[66]  J. Darnell,et al.  The Significance of Tetramerization in Promoter Recruitment by Stat5 , 1999, Molecular and Cellular Biology.

[67]  M. Caligiuri,et al.  FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications. , 2008, Blood.

[68]  J. Köhl,et al.  Anaphylatoxins and infectious and non-infectious inflammatory diseases. , 2001, Molecular immunology.

[69]  S. Melmed,et al.  Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[70]  B. Groner,et al.  Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter , 1997, Molecular and Cellular Endocrinology.

[71]  J. Grandis,et al.  Constitutive activation of Stat5b contributes to carcinogenesis in vivo. , 2003, Cancer research.

[72]  N. Copeland,et al.  Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK‐STAT5 pathway. , 1996, The EMBO journal.

[73]  L. Hennighausen,et al.  Stat5a is mandatory for adult mammary gland development and lactogenesis. , 1997, Genes & development.

[74]  Yusen Liu,et al.  Regulation of innate immune response by MAP kinase phosphatase-1. , 2007, Cellular signalling.

[75]  V. Moucadel,et al.  Differential STAT5 Signaling by Ligand-dependent and Constitutively Active Cytokine Receptors* , 2005, Journal of Biological Chemistry.

[76]  A. Yoshimura,et al.  CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. , 1997, Blood.

[77]  W. Hiddemann,et al.  The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3. , 2003, Blood.

[78]  W. Leonard,et al.  Stat5b Is Essential for Natural Killer Cell–mediated Proliferation and Cytolytic Activity , 1998, The Journal of experimental medicine.

[79]  H. Rui,et al.  Prolactin Stimulates Serine/Tyrosine Phosphorylation and Formation of Heterocomplexes of Multiple Stat5 Isoforms in Nb2 Lymphocytes* , 1997, The Journal of Biological Chemistry.

[80]  F. Gouilleux,et al.  A Sequence of the CIS Gene Promoter Interacts Preferentially with Two Associated STAT5A Dimers: a Distinct Biochemical Difference between STAT5A and STAT5B , 1998, Molecular and Cellular Biology.

[81]  J. Frasor,et al.  Differential Roles for Signal Transducers and Activators of Transcription 5 a and 5 b in PRL Stimulation of ER and ER Transcription , 2001 .

[82]  S. Moro,et al.  DNA Binding Site Selection of Dimeric and Tetrameric Stat5 Proteins Reveals a Large Repertoire of Divergent Tetrameric Stat5a Binding Sites , 2000, Molecular and Cellular Biology.

[83]  L. Haldosen,et al.  EGF modulates expression of STAT5 in mammary epithelial cells. , 1998, Experimental cell research.

[84]  Michael P. Brown,et al.  Stat5a and Stat5b Proteins Have Essential and Nonessential, or Redundant, Roles in Cytokine Responses , 1998, Cell.

[85]  M. D'urso,et al.  The structure of human STAT5A and B genes reveals two regions of nearly identical sequence and an alternative tissue specific STAT5B promoter. , 2002, Gene.

[86]  E. Lees,et al.  Chromatin acetylation and remodeling at the Cis promoter during STAT5-induced transcription. , 2003, Nucleic acids research.

[87]  J. Frasor,et al.  Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription. , 2001, Molecular endocrinology.

[88]  P. Furth,et al.  Loss of Stat5a delays mammary cancer progression in a mouse model , 2002, Oncogene.

[89]  V. Dixit,et al.  Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity , 2000, Nature Immunology.

[90]  A. Miyajima,et al.  Suppression of interleukin‐3‐induced gene expression by a C‐terminal truncated Stat5: role of Stat5 in proliferation. , 1996, The EMBO journal.

[91]  Z. Wang,et al.  Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. , 2001, Journal of veterinary science.

[92]  M. Braun,et al.  Renal Expression of the C3a Receptor and Functional Responses of Primary Human Proximal Tubular Epithelial Cells1 , 2004, The Journal of Immunology.

[93]  P. Bucher,et al.  DNA Binding Specificity of Different STAT Proteins , 2001, The Journal of Biological Chemistry.

[94]  R. Quigg,et al.  Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis1 , 2005, The Journal of Immunology.

[95]  Margarita Martinez-Moczygemba,et al.  Biology of common β receptor–signaling cytokines: IL-3, IL-5, and GM-CSF , 2003 .